ERS 2020

Inhaled corticosteroids are overused in patients with COPD and there is now clear evidence on which patients will most benefit, the European Respiratory Society 2020 virtual conference has heard. But there is a danger that too much focus is given to...

Inhaled corticosteroids are overused in patients with COPD and there is now clear evidence on which patients will most benefit,...

There is now "more than enough" evidence to implement screening programs for lung cancer, the lead author of a European Respiratory Society review paper on the topic told delegates at the society's virtual annual conference. In a debate session during ERS2020,...

There is now "more than enough" evidence to implement screening programs for lung cancer, the lead author of a European...

An open-label extension trial of dupilumab for up to three years in adults and adolescents with moderate-to-severe asthma has confirmed the safety and efficacy profile observed in shorter duration phase 2 and 3 studies. The LIBERTY ASTHMA TRAVERSE study, presented at...

An open-label extension trial of dupilumab for up to three years in adults and adolescents with moderate-to-severe asthma has confirmed...